Pharmacogenomics and drug development (Q36317013)

13 August 2017

1 reference

title

Pharmacogenomics and drug development. (English)

1 reference

13 August 2017

1 reference

Steven Shafer

2

0 references

author name string

Yingying Guo

1

1 reference

13 August 2017

Paul Weller

3

1 reference

13 August 2017

Jonathan Usuka

4

1 reference

13 August 2017

Gary Peltz

5

1 reference

13 August 2017

1 December 2005

1 reference

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

8

1 reference

13 August 2017

857-864

1 reference

In silico genetics: identification of a functional element regulating H2-Ealpha gene expression

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Chemical genomics in yeast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

CYP2C19 polymorphism and proton pump inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

HIV pharmacogenomics: closer to personalized therapy?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Regulation of bone mass in mice by the lipoxygenase gene Alox15

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Human Immunodeficiency Virus Type 1 Pharmacogenomics in Clinical Practice: Relevance of HIV-1 Drug Resistance Testing (Part 1)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Viral load detectability profiles for HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473028

Computational genetics: from mouse to human?

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.2217/14622416.6.8.857

From the molecule to the clinic--inhibiting HER2 to treat breast cancer

21 January 2018

1 reference

12 December 2020

Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial

1 reference

12 December 2020

Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma

1 reference

12 December 2020

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus

1 reference

12 December 2020

Identifiers

DOI

10.2217/14622416.6.8.857

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

16296948

1 reference